The Gastroparesis Market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027; it is expected to grow at a CAGR of 4% during 2021–2027.
Gastroparesis is a medical condition of the stomach that affects the normal voluntary movement of the stomach muscles. It limits normal digestion, causes vomiting, and causes problems with blood sugar levels and nutrition. Various drugs or drugs are prescribed to treat gastroparesis, such as reglan, erythromycin, and antiemetics. The increasing number of surgeries that cause gastroparesis after surgery, an increasing number of diabetic populations, an increasing elderly population, and the introduction of new drugs to control symptoms such as nausea and vomiting are driving the market.
(Get 15% Discount on Buying this Report)
A full report of Global Gastroparesis Market is available at: https://www.orionmarketreports.com/gastroparesis-market/61367/
Market Segments
By Drug Class
- Prokinetic Agents
- Antiemetic Agents
- Botulinum Toxin Injections
By Disease Type
- Diabetic Gastroparesis
- Idiopathic Gastroparesis
- Post-surgical Gastroparesis
- Others
By End-User
- Hospitals
- Pharmacies
- Clinics
- E-commerce
Key Players
EVOKE PHARMA, Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., and Cinrx Pharma, LLC (Cindome Pharma) are among the key companies operating in the global gastroparesis market.
Scope of the Report
The research study analyzes the global Gastroparesis industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Gastroparesis Market Report
1. What was the Gastroparesis Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Gastroparesis Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Gastroparesis Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Gastroparesis market.
- The market share of the global Gastroparesis market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Gastroparesis market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Gastroparesis market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
